We are testing the safety and effectiveness of EP102 in patients with advanced solid tumors. This study aims to see if it can provide better treatment options for these patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced solid tumors refer to cancerous growths that have progressed beyond the initial site and may have spread to other parts of the body. These tumors can arise in various organs, including the lungs, breast, and colon, and often require specialized treatment approaches.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
